Digital Transformation in Medical Affairs Sparked by the Pandemic: Insights and Learnings from COVID-19 Era and Beyond
- 31 December 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pharmaceutical Medicine
- Vol. 36 (1), 1-10
- https://doi.org/10.1007/s40290-021-00412-w
Abstract
A number of developments, including increasing regulatory and compliance scrutiny, increased transparency expectations, an increasingly vocal patient, patient centricity and greater requirements for real-world evidence, have driven the growth and importance of medical affairs as a trusted, science-driven partner over the past decade. The healthcare environment is shifting towards a digital, data-driven and payor-focused model. Likewise, medical affairs as a function within the pharmaceutical industry has become more “patient-centric” with strategic engagements embracing payers and patients apart from clinicians. The pandemic has impacted the healthcare industry as well as the function of medical affairs in numerous ways and has brought new challenges and demands to tackle. There is indeed a silver lining due to intense digital transformation within this crisis. The emerging digital innovation and new technologies in healthcare, medical education and virtual communications are likely to stay and advance further. In this review, we discuss how the digital transformation sparked by the pandemic has impacted the medical affairs function in pharmaceuticals and provide further insights and learnings from the COVID-19 era and beyond. Based on the learning and insights, digital innovation in three key strategic imperatives of medical affairs—HCP engagement, external partnerships and data generation will enable medical affairs to become future-fit as a strategic leadership function.Keywords
This publication has 70 references indexed in Scilit:
- Patient Centricity and Pharmaceutical Companies: Is It Feasible?Therapeutic Innovation & Regulatory Science, 2017
- Reflective practice and its role in facilitating creative responses to dilemmas within clinical communication - a qualitative analysisBMC Medical Education, 2016
- The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic reviewPatient Preference and Adherence, 2016
- The Importance Of Integrating Narrative Into Health Care Decision MakingHealth Affairs, 2016
- Early access programs: Benefits, challenges, and key considerations for successful implementationPerspectives in Clinical Research, 2016
- Implementing research results in clinical practice- the experiences of healthcare professionalsBMC Health Services Research, 2015
- Pharmaceutical industry, academia and patient advocacy organizations: What is the recipe for synergic (win–win–win) collaborations?Respirology, 2015
- A Survey of Key Opinion Leaders to Support Curriculum Development in Advanced Medical Science Liaison TrainingTherapeutic Innovation & Regulatory Science, 2015
- Big Data And New Knowledge In Medicine: The Thinking, Training, And Tools Needed For A Learning Health SystemHealth Affairs, 2014
- Patient Empowerment: Consequences for Pharmaceutical Marketing and for the Patient–Physician RelationshipInternational Series in Quantitative Marketing, 2013